News – Page 520 – Endpoints News

With eyes on first allogeneic CAR-T approval, Precision touts 100% response in 'small niche' population

3 years ago

Moderna’s Cinderella story is getting a scary rewrite on Wall Street, and a top analyst points to one path to a ...

3 years ago

Astellas joins Pfizer in emerging North Carolina hub, unveiling new $100M gene therapy manufacturing site

3 years ago

Seeking to 'close the loop' in drug discovery with machine learning, Catalio-backed biotech emerges from semi-stealth

3 years ago

Latent or lytic infection? Doesn't matter, Danish biotech says for transplant-related cytomegalovirus drug

3 years ago

German startup jumps into the hot radiopharma space with a former Ipsen compound as lead program

3 years ago

FDA advisors vote 21-0, with one abstention, to authorize Novavax’s Covid-19 vaccine to be the fourth US option

3 years ago

Bristol Myers settles anti-generic HIV drug scheme allegations for almost $11M

3 years ago

Georgia senator urges majority leader Chuck Schumer to follow through on insulin cap legislation

3 years ago

FTC opens investigation into largest PBMs' anticompetitive practices

3 years ago

EQT's investment arm and Mubadala ink $3B deal for medical freight and storage company

3 years ago

Eli Lilly sued by whistleblower over drug manufacturing issues

3 years ago

New survey suggests many Black cancer patients aren't made aware of clinical trials

3 years ago

Bavarian Nordic fields 'overwhelming' interest in monkeypox vaccine

3 years ago

MarketingRx roundup: Roche joins bladder cancer ‘Don’t Go Red’ campaign; Qelbree ADHD med debuts first TV ad

3 years ago

Akili taps new commercial chief in advance of fall marketing launch for ADHD video game therapy

3 years ago

Form 483 reveals quality control questions and lack of training at Sun Pharma’s plant in India

3 years ago

Aiming to jump ahead of Big Pharma heavyweights, Seres moves to finalize C. difficile FDA pitch

3 years ago

A former Merck director's Pfizer-backed biotech will take on his old bosses in nascent LILRB field

3 years ago

Immatics and Editas partner on gene editing and T cells; Eyenovia founder to step down from CEO position

3 years ago

Lilly unveils early long-term data on eczema drug that could chip away at Dupixent market

3 years ago

Activist investors attempt to change the course at Radius Health, six months after two disappointing readouts

3 years ago

Covid-19 roundup: Merck, Ridgeback drop new analyses for molnupiravir; Veru submits EUA for antiviral treatment

3 years ago

Exclusive: GV’s David Schenkein turns to a familiar face at Novartis for his latest recruit as ...

3 years ago

First page Previous page 517 518 519520521 522 523 Next page Last page